ZeaVision Advisory Board
|
Dr. Robert L. Davis
O.D., F.A.A.O. |
|
Dr. N. Rex Ghormley
O.D., F.A.A.O. |
|
Dr. Victor E. Malinovsky
O.D., F.A.A.O. |
|
Dr. Glenda B. Secor
O.D., F.A.A.O. |
|
Dr. Jack J. Yager
O.D., F.A.A.O. |
|
|
|
A Letter from the Chairman
I would like to welcome you to our web site and tell you about ZeaVision®, the company, and our philosophy.
We are fortunate to live in a time when the Internet allows us to communicate directly with vision loss sufferers, their families,
eye care professionals, and support community. I promise to make this web site a dynamic source of useful information.
We welcome your input and look forward to hearing your ideas on how to better serve you. You can reach us at
info@ZeaVision.com.
I became interested in zeaxanthin and macular degeneration almost two decades ago after scientists in Boston and Miami identified it as part
of the macular pigment. From my years of work in nutrition and biochemistry, I knew this was an important discovery. Since the identification
of zeaxanthin and its important role in macular health, I have seen it as my mission to bring the benefits of zeaxanthin to a wider audience.
As part of that mission, I have taken both personal and financial risks. I have underwritten work that has gone into zeaxanthin research and development.
I believe I was the first human to take large purified quantities of zeaxanthin over extended periods of time, and I continue to take it now.
As one of the founders of ZeaVision, LLC, I am pleased to introduce these products to the market place. In addition, and more recently we have
introduced a program called QuantifEYE®, that offers a device, that can measure the levels of this critical nutrient in the eye.
This will allow, for the first time, the ability to quantify the increase of a critical nutrient in the eye in response to supplementation.
This is a major advance in preventative eye care and we are proud to be part of the introduction. The launch of ZeaVision was
the result of the collective work of eye-care professionals, scientists, vision loss foundations and many business colleagues and partners over the last 20 years.
While it is deeply satisfying to introduce EyePromise® products to an under-served market, it must not be viewed as an end goal. We see it as a starting point. In that spirit, we
would like to make some promises to you about ZeaVision and our products.
Continue to monitor the safety and quality of our product and
to introduce new products when research suggests that additional benefits are possible.
Communicate information about our products and their benefits in a direct manner without misleading claims.
Continue to use Information Technology and the Internet as a catalyst for improving communication between the various communities,
including macular degeneration sufferers, personal and professional caregivers, and the scientific community.
Continue to build an organization of dedicated and compassionate employees that are responsive to the macular degeneration community.
Reinvest financial gains of our for-profit organization by selectively and efficiently supporting research and low vision organizations.
ZeaVision — The Hope
ZeaVision, LLC was started by individuals who want to make a difference. I am proud of what we have accomplished so far, but know that much
remains to be done. It is our fervent hope that ZeaVision, and our products, will help those at risk of, or currently suffering from acquired vision loss.
Also I hope this letter and our web site will give you a sense of who we are and the passion we bring to what we do. We want to serve you better, so please don't hesitate to write us.
Sincerely,
Dennis L. Gierhart, Ph.D.
Chairman & CEO
|
Dennis L. Gierhart, Ph.D.
Dennis L. Gierhart, ZeaVision Chairman, Chief Executive Officer and member of the Executive Committee. Dr. Gierhart received his
Ph.D. from Cornell University in 1978 in Food and Industrial Microbiology and his B.S. and M.S. degrees from Ohio State University in
1973 and 1974, respectively. From 1986 to 1998, Dr. Gierhart was founder and President of Applied Food Biotechnology, Inc., a food/feed ingredient company. Dr. Gierhart helped build
Applied Food Biotechnology from a one-person operation to an international operation with facilities on four continents. In addition to being the
company's founder, Dr. Gierhart served in various capacities including President. Prior to founding Applied Food Biotechnology, Dr. Gierhart directed
corporate research programs for two Fortune 500 food companies.
|
|
 |
In addition to serving as company Chairman, member of the Executive Committee and CEO, Dr. Gierhart's responsibilities at ZeaVision include a leadership
role in scientific research and development. In addition Dr. Gierhart is principal in Terra Investments, a real estate company.
|
Terry B. Hatfield
Terry B. Hatfield, President and member of the Executive Committee. Mr. Hatfield has a B.A. in Chemistry
from the University of Louisville in 1970 and has held numerous executive level positions in the food and biotech arena.
From 1982 to 1991 he was the Vice President and General Manager in the Dairy Foods System of Ralston Purina. From
1991 to 1994 Mr. Hatfield served as Vice President of European Market Operations for Protein Technologies, Inc. (PTI) in
Brussels, Belgium. From 1994 to 1998 he served as the Executive Vice President of Global Market Operations for PTI and in
1998 he assumed the responsibility of Co-President for PTI during the acquisition by DuPont. In 2001 Mr. Hatfield left to
pursue a consulting career where he has been heavily involved with mergers and acquisitions, as well as consulting for
several St. Louis area companies.
|
|
 |
Mr. Hatfield is also involved with the World Affairs Council, where he currently serves as the President.
He is the Vice Chairman of the Boeing Institute Board St. Louis University, a Board member of the Scholarship
Foundation of St. Louis, and a member of the board of Directors of KV Pharmaceutical.
Mr. Hatfield is responsible for all aspects of the day to day operation of ZeaVision’s business and a key contributor to the Executive Committee.
|
|